Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …

Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions,
has garnered widespread attention as a potential treatment for COVID-19 infection. The …

Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which
occurs in both genders, and across racial/ethnic and age groups; however, higher rates are …

Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …

Comment e614 www. thelancet. com/rheumatology Vol 3 September 2021 is that side-effects
after COVID-19 vaccination in patients with SLE are common (around 50%) but do not …

Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease,
represents a significant challenge for both diagnosis and treatment. Patients with SLE in …

Purpose To determine the association between the number of flares systemic lupus
erythematosus (SLE) patients experience and damage accrual, independently of other known risk …

Introduction Several months into the COVID-19 pandemic, safe and effective treatments
against this global health disaster have yet to be identified. Clinical research trials around the …

Before widespread vaccination programmes, potential side-effects and flares after COVID-19
vaccination were frequent reasons for vaccine hesitancy among people with rheumatic …